Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G.

Arch Neurol. 2000 Oct;57(10):1439-43.

PMID:
11030795
2.
3.

An economic analysis of the Atorvastatin Comparative Cholesterol Efficacy and Safety Study (ACCESS).

Smith DG, McBurney CR.

Pharmacoeconomics. 2003;21 Suppl 1:13-23.

PMID:
12648031
4.

Relation between cholesterol levels, statins and Alzheimer's disease in the human population.

Austen B, Christodoulou G, Terry JE.

J Nutr Health Aging. 2002;6(6):377-82. Review.

PMID:
12459888
5.

Prevalence and treatment of dyslipidemia in Canadian primary care: a retrospective cohort analysis.

Petrella RJ, Merikle E, Jones J.

Clin Ther. 2007 Apr;29(4):742-50.

PMID:
17617298
6.

Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care setting.

Bullano MF, Wertz DA, Yang GW, Kamat S, Borok GM, Gandhi S, McDonough KL, Willey VJ.

Pharmacotherapy. 2006 Apr;26(4):469-78.

PMID:
16553504
7.
8.

Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.

Zandi PP, Sparks DL, Khachaturian AS, Tschanz J, Norton M, Steinberg M, Welsh-Bohmer KA, Breitner JC; Cache County Study investigators..

Arch Gen Psychiatry. 2005 Feb;62(2):217-24.

PMID:
15699299
9.

Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study.

Haag MD, Hofman A, Koudstaal PJ, Stricker BH, Breteler MM.

J Neurol Neurosurg Psychiatry. 2009 Jan;80(1):13-7. doi: 10.1136/jnnp.2008.150433.

PMID:
18931004
10.

Health-related quality of life and long-term therapy with pravastatin and tocopherol (vitamin E) in older adults.

Carlsson CM, Papcke-Benson K, Carnes M, McBride PE, Stein JH.

Drugs Aging. 2002;19(10):793-805.

PMID:
12390056
11.

Cholesterol and Alzheimer's disease.

Wolozin B.

Biochem Soc Trans. 2002 Aug;30(4):525-9. Review.

PMID:
12196129
12.
13.

Do statins slow down Alzheimer's disease? A review.

Caballero J, Nahata M.

J Clin Pharm Ther. 2004 Jun;29(3):209-13. Review.

PMID:
15153082
14.
15.

Differential association between statin exposure and elevated levels of creatine kinase.

Chan J, Hui RL, Levin E.

Ann Pharmacother. 2005 Oct;39(10):1611-6.

PMID:
16160000
16.

An analysis of cholesterol control and statin use in the Losartan Intervention for Endpoint Reduction in Hypertension Study.

Kristianson K, Fyhrquist F, Devereux RB, Kjeldsen SE, Lindholm LH, Lyle PA, Nieminen MS, Snapinn SM.

Clin Ther. 2003 Apr;25(4):1186-99.

PMID:
12809965
17.

Serum cholesterol and risk of Alzheimer disease: a community-based cohort study.

Li G, Shofer JB, Kukull WA, Peskind ER, Tsuang DW, Breitner JC, McCormick W, Bowen JD, Teri L, Schellenberg GD, Larson EB.

Neurology. 2005 Oct 11;65(7):1045-50.

PMID:
16217057
19.

Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency.

Tonelli M, Moyé L, Sacks FM, Kiberd B, Curhan G; Cholesterol and Recurrent Events (CARE) Trial Investigators..

Ann Intern Med. 2003 Jan 21;138(2):98-104.

PMID:
12529091
20.
Items per page

Supplemental Content

Support Center